CapsoVision Aktie News
7,28 $
1,22 %
Nasdaq
,
2. Juli, 16:00 Uhr EDT.
tracken
CapsoVision Aktie News
SARATOGA, Calif., 02. Juli 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), ein Unternehmen der kommerziellen Phase für Medizintechnik, das fortschrittliche Bildgebungs- und KI-gestützte Kapselendoskopie-Lösungen entwickelt, gab die Ernennung von David S. Shields, M.D., bekannt.
CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript
SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for its first quarter ended March 31, 2026.
SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release first quarter 2026 financial results on Thursday, May 14, 2026, after the close of market. CapsoVision will host a corresponding conference call and...
CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript
Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results
SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company will release fourth quarter and full year 2025 financial results on Thursday, March 26, 2026, after the close of market.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
